Structure function analysis of SH2D2A isoforms expressed in T cells reveals a crucial role for the proline rich region encoded by SH2D2A exon 7

BMC Immunology

Volumn 7, Issue , 2006, Pages

  Granum, Stine ^a   Sundvold Gjerstad, Vibeke ^a   Dai, Ke Zheng ^a   Kolltveit, Kristin Melkevik ^a   Hildebrand, Kjersti ^a   Huitfeldt, Henrik S ^b   Lea, Tor ^b   Spurkland, Anne ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; AMINO ACID; CD3 ANTIGEN; ISOPROTEIN; PROLINE; PROTEIN KINASE LCK; PROTEIN SH2D2A; PROTEIN SH3; RNA; TYROSINE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CD4+ T LYMPHOCYTE; CELL NUCLEUS; CONTROLLED STUDY; EX VIVO STUDY; EXON; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; PROTEIN VARIANT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL NUCLEUS; EXONS; GENE EXPRESSION; HUMANS; JURKAT CELLS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROLINE; PROTEIN ISOFORMS; RNA, MESSENGER; SRC HOMOLOGY DOMAINS; STRUCTURE-ACTIVITY RELATIONSHIP; TYROSINE;

EID: 33748046789     PISSN: 14712172     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-7-15     Document Type: Article

References (42)

1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody J, Baldwin MC, et al.: Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
2. Leipzig J, Pevzner P, Heber S: The Alternative Splicing Gallery (ASG): bridging the gap between genome and transcriptome. Nucleic Acids Res 2004, 32:3977-3983.
3. Smith CW, Valcarcel J: Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem Sci 2000, 25:381-388.
4. Graveley BR: Alternative splicing: increasing diversity in the proteomic world. Trends Genet 2001, 17:100-107.
5. Klemm JD, Schreiber SL, Crabtree GR: Dimerization as a regulatory mechanism in signal transduction. Annu Rev Immunol 1998, 16:569-592.
6. Taneri B, Snyder B, Novoradovsky A, Gaasterland T: Alternative splicing of mouse transcription factors affects their DNA-binding domain architecture and is tissue specific. Genome Biol 2004, 5:R75.
7. Xu Q, Modrek B, Lee C: Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucleic Acids Res 2002, 30:3754-3766.
8. Trowbridge IS, Thomas ML: CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 1994, 12:85-116.
9. Novak TJ, Farber D, Leitenberg D, Hong SC, Johnson P, Bottomly K: Isoforms of the transmembrane tyrosine phosphatase CD45 differentially affect T cell recognition. Immunity 1994, 1:109-119.
10. McKenney DW, Onodera H, Gorman L, Mimura T, Rothstein DM: Distinct isoforms of the CD45 protein-tyrosine phosphatase differentially regulate interleukin 2 secretion and activation signal pathways involving Vav in T cells. J Biol Chem 1995, 270:24949-24954.
11. Leitenberg D, Novak TJ, Farber D, Smith BR, Bottomly K: The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation. J Exp Med 1996, 183:249-259.
12. Irles C, Symons A, Michel F, Bakker TR, Van Der Merwe PA, Acuto O: CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling. Nat Immunol 2003, 4:189-197.
13. Spurkland A, Brinchmann JE, Markussen G, Pedeutour F, Munthe E, Lea T, Vartdal F, Aasheim HC: Molecular cloning of a T cell-specific adapter protein (TSAd) containing an Src homology (SH) 2 domain and putative SH3 and phosphotyrosine binding sites. J Biol Chem 1998, 273:4539-4546.
14. Dai KZ, Vergnaud G, Ando A, Inoko H, Spurkland A: The SH2D2A gene encoding the T cell specific adapter protein (TSAd) is localized centromeric to the CD1 gene cluster on chromosome 1. Immunogenetics 2000, 51:179-185.
15. Simeoni L, Kliche S, Lindquist J, Schraven B: Adaptors and linkers in T and B cells. Curr Opin Immunol 2004, 16:304-313.
16. Choi YB, Kim CK, Yun Y: Lad, an adapter protein interacting with the SH2 domain of p56lck, is required for T cell activation. J Immunol 1999, 163:5242-5249.
17. Rajagopal K, Sommers CL, Decker DC, Mitchell EO, Korthauer U, Sperling AI, Kozak CA, Love PE, Bluestone JA: RIBP, a novel Rlk/Txk- and itk-binding adaptor protein that regulates T cell activation. J Exp Med 1999, 190:1657-1668.
18. Sun W, Kesavan K, Schaefer BC, Garrington TP, Ware M, Johnson NL, Gelfand EW, Johnson GL: MEKK2 associates with the adapter protein Lad/ RIBP and regulates the MEK5-BMK1/ERK5 pathway. J Biol Chem 2001, 276:5093-5100.
19. Sundvold-Gjerstad V, Granum S, Mustelin T, Andersen TC, Berge T, Shapiro MJ, Shapiro VS, Spurkland A, Lea T: The C terminus of T cell-specific adapter protein (TSAd) is necessary for TSAd-mediated inhibition of Lck activity. Eur J Immunol 2005, 35:1612-1620.
20. Marti F, King PD: The p95-100 kDa ligand of the T cell-specific adaptor (TSAd) protein Src-homology-2 (SH2) domain implicated in TSAd nuclear import is p97 Valosin-containing protein (VCP). Immunol Lett 2005, 97:235-243.
21. Wu LW, Mayo LD, Dunbar JD, Kessler KM, Ozes ON, Warren RS, Donner DB: VRAP is an adaptor protein that binds KDR, a receptor for vascular endothelial cell growth factor. J Biol Chem 2000, 275:6059-6062.
22. Matsumoto T, Bohman S, Dixelius J, Berge T, Dimberg A, Magnusson P, Wang L, Wikner C, Qi JH, Wernstedt C, Wu J, Bruheim S, Mugishima H, Mukhopadhyay D, Spurkland A, Claesson-Welsh L: VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO J 2005, 24:2342-2353.
23. Sundvold V, Torgersen KM, Post NH, Marti F, King PD, Rottingen JA, Spurkland A, Lea T: Cutting edge: T cell-specific adapter protein inhibits T cell activation by modulating Lck activity. J Immunol 2000, 165:2927-2931.
24. Marti F, Garcia GG, Lapinski PE, MacGregor JN, King PD: Essential role of the T cell-specific adapter protein in the activation of LCK in peripheral T cells. J Exp Med 2006, 203:281-287.
25. Marti F, Post NH, Chan E, King PD: A transcription function for the T cell-specific adapter (TSAd) protein in T cells: critical role of the TSAd Src homology 2 domain. J Exp Med 2001, 193:1425-1430.
26. Drappa J, Kamen LA, Chan E, Georgiev M, Ashany D, Marti F, King PD: Impaired T cell death and lupus-like autoimmunity in T cell-specific adapter protein-deficient mice. J Exp Med 2003, 198:809-821.
27. Sun W, Wei X, Kesavan K, Garrington TP, Fan R, Mei J, Anderson SM, Gelfand EW, Johnson GL: MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src. Mol Cell Biol 2003, 23:2298-2308.
28. Park D, Choi YB, Han MK, Kim UH, Shin J, Yun Y: Adaptor protein Lad relays PDGF signal to Grb2 in lung cells: a tissue-specific PDGF signal transduction. Biochem Biophys Res Commun 2001, 284:275-281.
29. Obenauer JC, Cantley LC, Yaffe MB: Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 2003, 31:3635-3641.
30. Williams BL, Irvin BJ, Sutor SL, Chini CC, Yacyshyn E, Bubeck WJ, Dalton M, Chan AC, Abraham RT: Phosphorylation of Tyr319 in ZAP-70 is required for T-cell antigen receptor-dependent phospholipase C-gamma1 and Ras activation. EMBO J 1999, 18:1832-1844.
31. Pelosi M, Di BV, Mounier V, Mege D, Pascussi JM, Dufour E, Blondel A, Acuto O: Tyrosine 319 in the interdomain B of ZAP-70 is a binding site for the Src homology 2 domain of Lck. J Biol Chem 1999, 274:14229-14237.
32. Paz PE, Wang S, Clarke H, Lu X, Stokoe D, Abo A: Mapping the Zap-70 phosphorylation sites on LAT (linker for activation of T cells) required for recruitment and activation of signalling proteins in T cells. Biochem J 2001, 356:461-471.
33. Jones RB, Gordus A, Krall JA, MacBeath G: A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 2006, 439:168-174.
34. Kolaskar AS, Tongaonkar PC: A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 1990, 276:172-174.
35. Parker JM, Guo D, Hodges RS: New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 1986, 25:5425-5432.
36. Dai KZ, Johansen FE, Kolltveit KM, Aasheim HC, Dembic Z, Vartdal F, Spurkland A: Transcriptional activation of the SH2D2A gene is dependent on a cyclic adenosine 5′-monophosphate-responsive element in the proximal SH2D2A promoter. J Immunol 2004, 172:6144-6151.
37. Barik S: Mutagenesis and gene fusion by megaprimer PCR. Methods Mol Biol 1997, 67:173-182.
38. Rasmussen AM, Smeland EB, Erikstein BK, Caignault L, Funderud S: A new method for detachment of Dynabeads from positively selected B lymphocytes. J Immunol Methods 1992, 146:195-202.
39. Clipstone NA, Crabtree GR: Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 1992, 357:695-697.
40. amaxa: Amaxa Biosystem [http://www.amaxa.com/]. 2006.
41. Dai KZ, Harbo HF, Celius EG, Oturai A, Sorensen PS, Ryder LP, Datta P, Svejgaard A, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Myhr KM, Nyland H, Vartdal F, Spurkland A: The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Genes Immun 2001, 2:263-268.
42. NCBI-Blast: [http://www.ncbi.nlm.nih.gov/BLAST/]. 2006.